Integrity Researchwatch has moved to
http://www.integrity-research.com/cms/researchwatch
Please update your bookmarks.



Subscribe to Integrity ResearchWatch by Email
or  in an RSS/XML reader

For those of you who don't know about Integrity Research Associates, we publish syndicated research reports; provide an online database of reviews, analysis and ratings on research firms; and offer specialized consulting about the equity research industry for professionals at money management, hedge fund, and broker / dealer firms. You can learn more about our company and our products / services at www.integrity-research.com.


Please feel free to contact us about our company, our products, or our services using the contact information below.
Integrity Research Associates, LLC
1115 Broadway, 12th Floor
New York, NY 10010

Tel: 212-845-9088
Fax: 212-845-9091
E-Mail: info@integrity-research.com
URL: www.integrity-research.com

Investorside Research Association


<< March 2007 >>
Sun Mon Tue Wed Thu Fri Sat
 01 02 03
04 05 06 07 08 09 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31


If you want to be updated on this weblog Enter your email here:



rss feed



Friday, March 09, 2007
Credit Suisse's CSA Program

New York—A recent article in Wall Street & Technology examines Wall Street’s recent push to promote commission sharing arrangements (CSAs), profiling Credit Suisse’s CSA platform, Research Exchange (Rx). The article highlights the ‘land grab’ which is occurring as bulge bracket brokers are pushing to add market share.  It also hints at the consequences of the current CSA push, which may not entirely be to Wall Street’s liking.  

Credit Suisse’s CSA program is a global blanket agreement that applies to all asset classes, although it focuses primarily on equities.  The primary selling point for CSA’s is is the ability to consolidate trading counterparties.  According to the article, Credit Suisse's clients are attempting to cut their broker lists from 100 to 30, while the largest money managers that have 250 brokers would like to cut that down to 100.  This is what is motivating securities firms to aggressively promote CSAs.

According to the article, the other motivator driving the adoption of CSAs is that the buy side is looking to place a value on the research.  In our view, this is less a driver to the process, and more a consequence.  As CSAs become more prevalent, commissions get increasingly split between execution and research.  And, as the CSAs process evolves, the dialogue ceases to be about best execution and shifts toward “best research”, i.e. which providers are adding value and how much value they offer.  Credit Suisse is promoting this as a benefit of its platform: "Rx helps segment where the value exists, both in the execution venue and in the research providers who are providing the best research," according to Manny Santayana, MD and head of sales for CS’s algorithmic trading capabilities.

The reality is that this is uncharted territory.  Most buy side clients have yet to assimilate the basic fact that obtaining Wall Street proprietary research through full service commissions is defined as soft dollars under the SEC July 2006 soft dollar guidance.  They are not yet focused evaluating research with the same gusto that they are now re-evaluating trading counterparties.  That time is coming and in the meantime, the Street is starting to hedge its bets by more proactively offering third party research alongside its own proprietary research, through efforts such as Goldman’s Hudson Street Services.    

The article concludes with a prediction that, with or without SEC commission disclosure guidelines, full service commissions will become transparent: “So what will happen to full-service trades? ‘It's all going to unbundling," predicts Santayana. ‘Unbundling seems to be the right thing to do as a fiduciary at this point.’"

For the complete article, click here.


Posted at 11:22 am by Sanford (Sandy) Bragg
Comments (1)  

Next Page